Literature DB >> 11149570

The basic pathology of human breast cancer.

E Mallon1, P Osin, N Nasiri, I Blain, B Howard, B Gusterson.   

Abstract

This article illustrates the most common benign and malignant lesions in the breast, and is intended for the biologist working in the area of breast cancer and breast biology, not for the practicing pathologist. The atlas covers benign proliferative lesions, atypical lesions, variants of in situ cancer, the main types of invasive cancers, spindle cell lesions, and examples of vascular and lymphatic spread. Some entities are included to illustrate a point of particular relevance to the biology and histogenesis of the lesions. Some controversial diagnostic areas are considered, along with the relative risk of developing breast cancer associated with some of the proliferative lesions. The content of this atlas should be read in conjunction with the companion article by Howard and Gusterson in this issue. Their article covers the cellular origin of epithelial and stromal tumors and presents a description of some of the common benign proliferative lesions that are considered to be components of the normal spectrum of changes seen at postmortem or in biopsies.

Entities:  

Mesh:

Year:  2000        PMID: 11149570     DOI: 10.1023/a:1026439204849

Source DB:  PubMed          Journal:  J Mammary Gland Biol Neoplasia        ISSN: 1083-3021            Impact factor:   2.673


  54 in total

Review 1.  The significance of breast cancer lymph node micrometastases.

Authors:  T J Yeatman; C E Cox
Journal:  Surg Oncol Clin N Am       Date:  1999-07       Impact factor: 3.495

Review 2.  Comparative study of human and rat mammary tumorigenesis.

Authors:  J Russo; B A Gusterson; A E Rogers; I H Russo; S R Wellings; M J van Zwieten
Journal:  Lab Invest       Date:  1990-03       Impact factor: 5.662

3.  Gene expression profiles of laser-captured adjacent neuronal subtypes.

Authors:  L Luo; R C Salunga; H Guo; A Bittner; K C Joy; J E Galindo; H Xiao; K E Rogers; J S Wan; M R Jackson; M G Erlander
Journal:  Nat Med       Date:  1999-01       Impact factor: 53.440

4.  Outcome of primary-breast-cancer patients with micrometastases: a long-term follow-up study.

Authors:  J L Mansi; H Gogas; J M Bliss; J C Gazet; U Berger; R C Coombes
Journal:  Lancet       Date:  1999-07-17       Impact factor: 79.321

Review 5.  Anatomic markers of human premalignancy and risk of breast cancer.

Authors:  D L Page; W D Dupont
Journal:  Cancer       Date:  1990-09-15       Impact factor: 6.860

6.  High-throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma.

Authors:  H Moch; P Schraml; L Bubendorf; M Mirlacher; J Kononen; T Gasser; M J Mihatsch; O P Kallioniemi; G Sauter
Journal:  Am J Pathol       Date:  1999-04       Impact factor: 4.307

7.  Duct carcinoma in situ. Pathology and treatment.

Authors:  M D Lagios
Journal:  Surg Clin North Am       Date:  1990-08       Impact factor: 2.741

8.  p53 mutation with frequent novel condons but not a mutator phenotype in BRCA1- and BRCA2-associated breast tumours.

Authors:  T Crook; L A Brooks; S Crossland; P Osin; K T Barker; J Waller; E Philp; P D Smith; I Yulug; J Peto; G Parker; M J Allday; M R Crompton; B A Gusterson
Journal:  Oncogene       Date:  1998-10-01       Impact factor: 9.867

9.  Risk factors for breast cancer in women with proliferative breast disease.

Authors:  W D Dupont; D L Page
Journal:  N Engl J Med       Date:  1985-01-17       Impact factor: 91.245

10.  The relationship between micrometastases in the bone marrow, histopathologic features of the primary tumor in breast cancer and prognosis.

Authors:  U Berger; R Bettelheim; J L Mansi; D Easton; R C Coombes; A M Neville
Journal:  Am J Clin Pathol       Date:  1988-07       Impact factor: 2.493

View more
  17 in total

1.  Endonuclease G promotes cell death of non-invasive human breast cancer cells.

Authors:  Alexei G Basnakian; Eugene O Apostolov; Xiaoyan Yin; Stanley O Abiri; Anna G Stewart; Amar B Singh; Sudhir V Shah
Journal:  Exp Cell Res       Date:  2006-09-20       Impact factor: 3.905

2.  Iron-binding proteins and C-reactive protein in Nipple Aspirate Fluids: role of Iron-driven inflammation in breast cancer microenvironment?

Authors:  Ferdinando Mannello; Gaetana A Tonti; Patrizia Simone; Daniela Ligi; Virginia Medda
Journal:  Am J Transl Res       Date:  2010-10-30       Impact factor: 4.060

Review 3.  Human breast development.

Authors:  B A Howard; B A Gusterson
Journal:  J Mammary Gland Biol Neoplasia       Date:  2000-04       Impact factor: 2.673

4.  Progression to malignancy in the polyoma middle T oncoprotein mouse breast cancer model provides a reliable model for human diseases.

Authors:  Elaine Y Lin; Joan G Jones; Ping Li; Liyin Zhu; Kathleen D Whitney; William J Muller; Jeffrey W Pollard
Journal:  Am J Pathol       Date:  2003-11       Impact factor: 4.307

5.  Probability estimation models for prediction of BRCA1 and BRCA2 mutation carriers: COS compares favourably with other models.

Authors:  Hassan Roudgari; Zosia H Miedzybrodzka; Neva E Haites
Journal:  Fam Cancer       Date:  2007-12-21       Impact factor: 2.375

6.  A computational study of the development of epithelial acini: II. Necessary conditions for structure and lumen stability.

Authors:  Katarzyna A Rejniak; Alexander R A Anderson
Journal:  Bull Math Biol       Date:  2008-04-10       Impact factor: 1.758

7.  Effects of bazedoxifene acetate with and without conjugated equine estrogens on the breast of postmenopausal monkeys.

Authors:  Kelly F Ethun; Charles E Wood; Thomas C Register; J Mark Cline; Susan E Appt; Thomas B Clarkson
Journal:  Menopause       Date:  2012-11       Impact factor: 2.953

8.  Microenvironment driven invasion: a multiscale multimodel investigation.

Authors:  Alexander R A Anderson; Katarzyna A Rejniak; Philip Gerlee; Vito Quaranta
Journal:  J Math Biol       Date:  2008-10-07       Impact factor: 2.259

9.  Immunohistochemical evaluation of vasopressin expression in breast fibrocystic disease and ductal carcinoma in situ (DCIS).

Authors:  William G North; Wendy Wells; Michael J Fay; Rennie S Mathew; Edward M Donnelly; Vincent A Memoli
Journal:  Endocr Pathol       Date:  2003       Impact factor: 3.943

10.  Altered serotonin physiology in human breast cancers favors paradoxical growth and cell survival.

Authors:  Vaibhav P Pai; Aaron M Marshall; Laura L Hernandez; Arthur R Buckley; Nelson D Horseman
Journal:  Breast Cancer Res       Date:  2009-11-10       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.